FOXO TECHNOLOGIES INC. (FOXO) Earnings Signals & AI Vibe Check

Latest Filing: 10-K  |  Filed Apr 15, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for FOXO TECHNOLOGIES INC.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, FOXO TECHNOLOGIES INC.'s filing signal turned positive.
earningsVibe SuperAnalyst™ Verdict: TURNED POSITIVE

Signal Performance — Stock Price Since Filing

30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Turned Negative
CLAUDE
Continuing Negative
CHATGPT
Continuing Negative

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does FOXO TECHNOLOGIES INC. actually do?
Answer:
FOXO Technologies Inc. operates as a healthcare services and technology company with four synergistic divisions: rural hospital operations, mental and behavioral health services, information/data/biospecimen sourcing, and epigenetics diagnostics. The company aims to improve healthcare quality and lives through technology and expertise. Its acquisitions of Myrtle Recovery Centers, Rennova Community Health (including its subsidiary Scott County Community Health), and Vector BioSource have expanded its service offerings to include substance use disorder treatment, critical access hospital services, biospecimen sourcing for research, and epigenetic biomarker technology commercialization. FOXO's strategy involves organic expansion and strategic acquisitions within its core segments.
Question:
What are FOXO TECHNOLOGIES INC.'s revenue drivers?
Answer:
Revenue is primarily driven by hospital and ancillary services, substance abuse treatments, sales of biological materials to the pharmaceutical and biotechnology research sectors, and royalty income from epigenetic biomarker technology.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required